EichorEICHOR
Study identifier: NCT05475574 Synced from ClinicalTrials.gov · August 08, 2026
● Study status: RecruitingGer-SP

Impact of Discontinuing Contact Precautions for Extended-spectrum β-lactamase Enterobacteriaceae in a Geriatric Unit

Condition: Infection, Hospital  ·  Sponsor: Centre Hospitalier Régional Metz-Thionville

PhaseNA
Planned participants954
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersNoCheck eligibility criteria ↓
WhereMetz, France

Interested? Contact the study team ↓

Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.

About this study

This is an interventional multicenter prospective noninferiority non-randomized double-blind controlled before and after study. The aim of this study is to demonstrate that standard precautions alone are not inferior to contact precautions by comparing the incidence density of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae acquired in geriatric units before and after discontinuing contact precautions.

This description comes directly from the study's public registry record.

Talk to the study team

Laurie RENAUDIN, MD  ·  03 87 55 30 25  ·  l.renaudin@chr-metz-thionville.fr

Mathieu LLORENS, MD  ·  03 87 55 38 39  ·  m.llorens@chr-metz-thionville.fr

There is no obligation to join — the study team can answer your questions about taking part.

Always discuss trial participation with your own doctor first.

Full eligibility criteria (exactly as the study team wrote them)

Inclusion Criteria: * Adult patient (\> 65 years old) * Patient hospitalized in geriatrics during the study period * Free and informed consent obtained from the patient (or his trusted person or legal representative) within 48 hours of its admission at the geriatric unit * Patient affiliated to a social security scheme Non Inclusion Criteria: * Patient requiring contact precaution for an indication other than ESBLE (COVID-19, classical PCC excluding EBLSE, Clostridium difficile PCC, scabies PCC and BHRe PCC) on admission * Patient under legal protection * Person deprived of liberty Exclusion criteria: * Patient requiring contact precaution for an indication other than ESBL during the patient stay (COVID-19, classical PCC excluding EBLSE, Clostridium difficile PCC, scabies PCC and BHRe PCC) * Patient's stay period less than 4 days

Reproduced word-for-word from the public registry record — the study team can answer questions about it.

Locations (1)

CHR Metz-Thionville/Hôpital Bel AirMetz, FranceRecruiting

More studies in these areas

This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.

Metz

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →